CD274 and neoplasm: More interesting results were reported recently regarding [89Zr]Zr-DFO-KN035 PET/CT [33], a new tracer targeting KN035, which is an anti-PD-L1 monodomain antibody drug for tumor immunotherapy, in clinical research and as a subcutaneous injection [34,35].